The optimal oral dose selection of ibandronate in Japanese patients with osteoporosis based on pharmacokinetic and pharmacodynamic properties

Ibandronate is a drug widely used outside Japan for the treatment of osteoporosis. It is available in formulations for intermittent intravenous (i.v.) administration and for intermittent (once monthly) oral administration. Ibandronate was recently approved in Japan as an i.v. injection with a dosing...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakai, Kiyohiko, Tobinai, Masato, Hashimoto, Junko, Iida, Satofumi, Kawanishi, Takehiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819509/
https://www.ncbi.nlm.nih.gov/pubmed/25476995
http://dx.doi.org/10.1007/s13318-014-0242-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819509/
https://www.ncbi.nlm.nih.gov/pubmed/25476995
http://dx.doi.org/10.1007/s13318-014-0242-5

Ejemplares similares